10 million people live with #IBD around the world. This #WorldIBDDay2024, we offer a reminder that #IBDhasnoborders and affects people around the world. We’re committed and working to help patients worldwide manage this chronic condition. #InnovatingAccess.
삼성바이오에피스
제약
Incheon Incheon 팔로워 74,204명
We make high quality biologic medicines more accessible, more quickly. #InnovatingAccess
소개
Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology and ophthalmology. For more information, please visit: www.samsungbioepis.com. To see our community guidelines, please visit: bit.ly/2l0yiI3
- 웹사이트
-
http://www.samsungbioepis.com/
삼성바이오에피스 외부 링크
- 업계
- 제약
- 회사 규모
- 직원 501 - 1,000명
- 본사
- Incheon Incheon
- 유형
- 비상장기업
- 설립
- 2012
- 전문 분야
- biosimilars, pharmaceutical, biopharmaceutical, biotechnology, regulatory affairs, clinical trials, research and development, novel biologic, oncology, immunology, ophthalmology, science, quality, innovation 및 healthcare
위치
-
기본
길 보기
KR Incheon Incheon 21987
삼성바이오에피스 직원
업데이트
-
Our VP and Head of U.S. Market Access Thomas M. Newcomer, MBA spoke about why now is the time to engage #biosimilars more into public disclosure as a way to help biosimilars play a role in bringing down healthcare costs. #PassionForHealth #InnovatingAccess
-
How often do you think about your eyes? Let us guess—probably not too often. May is #HealthyVisionMonth, we urge you to get your eyes checked, especially if you’re someone that spends a decent amount of time staring at your device screens.
-
It’s a busy week for our VP Gillian Woollett. Following Festival of Biologics, she will moderate Session 6 at #BIOS24 on April 19 in Amsterdam, where experts will explore the latest developments in #BiosimilarMedicines frameworks worldwide. Don't miss this opportunity to learn from global regulators. https://bit.ly/441X2AL
-
The Festival of Biologics which brings together experts in biologics and biotech from around the world kicks off today to this Wednesday in San Diego. The event will feature addresses from Samsung Bioepis' VP Gillian Woollett.
-
-
How well do you know your #biosimilar experts? Take a guess to find out who has your best interests in mind.
이 콘텐츠는 여기에서 사용할 수 없습니다.
LinkedIn 앱에서 이 콘텐츠 등 이용하기
-
For this #WorldHealthDay, the theme is #MyHealthMyRight. Since our start, we’ve been working hard to tackle health inequities by #InnovatingAccess for all through #biosimilars. Marking this World Health Day, let’s take a look at how biosimilars could help people have access to treatments. We will continue to build a fairer and healthier world together.
-
-
삼성바이오에피스님이 퍼감
Don't miss out on Gillian Woollett's upcoming talk, 'What in the World is going on with Biosimilars'!🌍 If you are passionate about #biosimilars, this is the session for you! Join us as she explores the current global biosimilar landscape, from a regulatory perspective, offering invaluable insights into the subject and practical applications. Register now to catch this opportunity to gain a comprehensive understanding of the current global biosimilar landscape👉 https://lnkd.in/eVJxatT8 #festivalofbiologicsUSA
-
-
Following our channel, but still not sure what a #biosimilar is? Or you know, but want a refresher? Take a look at these #FastFacts below and get familiar with biosimilars. #PassionForHealth
-